Junling Yang

4.3k total citations
109 papers, 3.2k citations indexed

About

Junling Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Junling Yang has authored 109 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 17 papers in Pharmacology. Recurrent topics in Junling Yang's work include Pharmacological Effects of Natural Compounds (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Ginseng Biological Effects and Applications (10 papers). Junling Yang is often cited by papers focused on Pharmacological Effects of Natural Compounds (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Ginseng Biological Effects and Applications (10 papers). Junling Yang collaborates with scholars based in China, United States and United Kingdom. Junling Yang's co-authors include Feifei Du, Chuan Li, F. Xu, Wei Niu, Yühong Huang, Bingdi Yan, Olajide E. Olaleye, Yan Sun, Xiumei Gao and Weiwei Jia and has published in prestigious journals such as The Science of The Total Environment, Scientific Reports and Environmental Health Perspectives.

In The Last Decade

Junling Yang

105 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junling Yang China 34 1.6k 523 384 355 339 109 3.2k
Chi‐Chen Lin Taiwan 35 1.9k 1.2× 317 0.6× 304 0.8× 366 1.0× 239 0.7× 213 5.0k
Dan Zhou China 30 1.2k 0.7× 164 0.3× 231 0.6× 319 0.9× 386 1.1× 148 3.2k
Yue Dai China 43 2.3k 1.4× 704 1.3× 660 1.7× 400 1.1× 122 0.4× 185 5.2k
Lili Ding China 40 2.0k 1.2× 436 0.8× 265 0.7× 553 1.6× 94 0.3× 151 4.9k
Jin Ren China 34 1.6k 1.0× 614 1.2× 233 0.6× 894 2.5× 81 0.2× 138 3.5k
Tianyu Liu China 32 2.3k 1.4× 207 0.4× 142 0.4× 238 0.7× 314 0.9× 100 3.4k
Yali Li China 34 1.3k 0.8× 164 0.3× 151 0.4× 312 0.9× 201 0.6× 161 3.6k
Yan Yang China 39 2.1k 1.3× 212 0.4× 166 0.4× 328 0.9× 427 1.3× 218 5.3k
Xinwen Wang China 38 1.7k 1.0× 381 0.7× 114 0.3× 387 1.1× 153 0.5× 154 4.6k

Countries citing papers authored by Junling Yang

Since Specialization
Citations

This map shows the geographic impact of Junling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junling Yang more than expected).

Fields of papers citing papers by Junling Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junling Yang. The network helps show where Junling Yang may publish in the future.

Co-authorship network of co-authors of Junling Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Junling Yang. A scholar is included among the top collaborators of Junling Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junling Yang. Junling Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jia, Weiwei, Zijing Song, Feifei Du, et al.. (2025). Guiding precision medicine strategy for intravenous ginsenosides via pharmacokinetic-informed bioinformatic approaches: a study on XueShuanTong. Phytomedicine. 143. 156716–156716. 1 indexed citations
3.
Hu, Xiao, Jie Tan, Yujuan Wang, et al.. (2025). Blocking IL-6 down-regulates PD-L1 expression and mitigates pulmonary fibrosis by inhibiting the STAT3 signaling pathway. Cellular Signalling. 135. 112019–112019. 2 indexed citations
4.
Li, Dongfu, et al.. (2024). Novel gene-based therapeutic approaches for the management of hepatic complications in diabetes: Reviewing recent advances. Journal of Diabetes and its Complications. 38(2). 108688–108688. 7 indexed citations
5.
Liu, Suyan, Yong Zhao, Xuan Tang, et al.. (2023). In vitro inhibition of six active sesquiterpenoids in zedoary turmeric oil on human liver cytochrome P450 enzymes. Journal of Ethnopharmacology. 322. 117588–117588.
6.
Jia, Shengnan, et al.. (2023). The role and mechanism of action of microbiota-derived short-chain fatty acids in neutrophils: From the activation to becoming potential biomarkers. Biomedicine & Pharmacotherapy. 169. 115821–115821. 33 indexed citations
7.
Zhou, Xin, Junling Yang, Lingling Ren, et al.. (2022). Molecular Basis Underlying Hepatobiliary and Renal Excretion of Phenolic Acids of Salvia miltiorrhiza Roots (Danshen). Frontiers in Pharmacology. 13. 911982–911982. 4 indexed citations
8.
Wang, Yujuan, et al.. (2020). Hypoxic Preconditioning of Human Umbilical Cord Mesenchymal Stem Cells Is an Effective Strategy for Treating Acute Lung Injury. Stem Cells and Development. 30(3). 128–134. 10 indexed citations
9.
Duan, Xiaoqin, et al.. (2020). Personal Protective Equipment in COVID-19. Journal of Occupational and Environmental Medicine. 63(3). 221–225. 28 indexed citations
10.
Niu, Wei, Olajide E. Olaleye, Yühong Huang, et al.. (2019). Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions. Acta Pharmacologica Sinica. 40(10). 1351–1363. 33 indexed citations
11.
Yu, Jinyan, Shanshan Meng, Fei Wu, et al.. (2018). Maternal exposure to farming environment protects offspring against allergic diseases by modulating the neonatal TLR-Tregs-Th axis. Clinical and Translational Allergy. 8(1). 34–34. 24 indexed citations
12.
Dong, Jiajia, Olajide E. Olaleye, Rongrong Jiang, et al.. (2018). Glycyrrhizin has a high likelihood to be a victim of drug–drug interactions mediated by hepatic organic anion‐transporting polypeptide 1B1/1B3. British Journal of Pharmacology. 175(17). 3486–3503. 21 indexed citations
13.
Zheng, Wenjie, Junling Yang, Zhizhen Dong, et al.. (2018). High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma. Cancer Management and Research. Volume 10. 5979–5989. 14 indexed citations
14.
Cheng, Chen, Olajide E. Olaleye, Yan Sun, et al.. (2018). Pharmacokinetics-Based Identification of Potential Therapeutic Phthalides from XueBiJing, a Chinese Herbal Injection Used in Sepsis Management. Drug Metabolism and Disposition. 46(6). 823–834. 29 indexed citations
15.
Yang, Junling, et al.. (2017). Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells. Experimental and Therapeutic Medicine. 14(1). 453–460. 13 indexed citations
16.
Jiang, Rongrong, Jiajia Dong, Xiuxue Li, et al.. (2014). Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside‐perpetrated herb–drug interactions on OATP1B3. British Journal of Pharmacology. 172(4). 1059–1073. 56 indexed citations
17.
Hu, Zheyi, Xiuxue Li, Feifei Du, et al.. (2013). Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals. Acta Pharmacologica Sinica. 34(11). 1437–1448. 9 indexed citations
18.
Yang, Junling. (2005). Detection of PNRSV and PDV in Peach and Cherry by RT-PCR. Guoshu xuebao. 3 indexed citations
19.
Yang, Junling, et al.. (2005). Assisted effects of lower limb orthosis on the recovery of activities of daily living and walking ability in spinal injured patients. 9(42). 68–69. 1 indexed citations
20.
Zhong, Yanwei, et al.. (2000). Expression of human single-chain variable fragment antibody against non-structural protein 3 of hepatitis C virus antigen in e.coli.. PubMed. 8(3). 171–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi‐Chen Lin Breakdown of academic impact, for papers by Dan Zhou Breakdown of academic impact, for papers by Yue Dai Breakdown of academic impact, for papers by Lili Ding Breakdown of academic impact, for papers by Jin Ren Breakdown of academic impact, for papers by Tianyu Liu Breakdown of academic impact, for papers by Yali Li Breakdown of academic impact, for papers by Yan Yang Breakdown of academic impact, for papers by Xinwen Wang
Rankless by CCL
2026